Daily clinical updates add to billions of datapoints leading to actionable insights for life science and healthcare researchers. Founded by innovative health system members, Truveta data includes over 50 million patient journeys (growing daily) from 700 hospitals and more than 20,000 clinics across the U.S. representing the full diversity of the country across age, geography, race, ethnicity, and gender.

Truveta offers unparalleled data depth with full patient medical records, not just claims data. Data is de-identified and normalized daily with advanced AI for easy actionable analysis, searchable with real medical expressions. In June 2022 the company announced a strategic collaboration to provide Pfizer with an unprecedented data platform for research. The data collected by Truveta are always flowing, providing the most up-to-date picture of U.S. health. Pfizer will use de-identified data from Truveta to identify, monitor, and evaluate potential signals in near-real time, informing efforts to mitigate risks and enabling further research.

It puts the researcher front and center – creating opportunities to access data for real-time learning. It uniquely connects life science and health system researchers to innovate collaboratively, speed time to insight, and earn trust through transparency and reproducibility of research. Truveta’s data platform empowers researchers to quickly monitor, query and evaluate health data from more than 50 million de-identified patient journeys, covering a broad range of diversity of the U.S. Data are updated daily and includes the full Electronic Medical Record (EMR), not just the medical bill from claims data, all fully anonymized and aggregated. This clinical data is linked across providers and with medical claims when care is provided outside Truveta’s network. Every patient record is enhanced with comprehensive socio-economic data and daily mortality data for a complete picture of each patient’s health journey.